Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial

Autor: Beaves, Emily, Breen, David, Burness, Christine, Caddy, Simone, Callaghan, Hannah, Carberry, Andrew, Chetham, Luke, Clyne, Andrea, Cobb, Susie, Coebergh, Jan, Cook, Lewis, Cookson, Patrick, Cooper, Paul, Diamond, Clare, Drake, Lee, Dunn, Victoria, Gardiner, Paula, Gilbertson, Thomas, Golder, Dawn, Gregory, Rebecca, Harbinson, Helen, Higgins, Rory, Hoeritzauer, Ingrid, Irvine, Laura, Isaacs, Jeremy, Jay, Emily, Kearney, Danielle, Khan, Uzma, Magro, James, Mallam, Elizabeth, Harle, Eleanor, Massey, Luke, McRae, Sarah, Misra, Shagun, Mitchell, Steph, Moss, Cameron, Mountain, Esther, Murray, Shona, Newby, Rachel, Novak, Marianne, Ross, Annie, Rutherford, Anna, Sare, Gillian, Sears, Rhiannon, Sedley, Will, Singhal, Sumeet, Stanton, Biba, Stone, Charlotte, Szeto, Gillian, Tarr, Lauren, Teodoro, Tiago, Teweleit, Volker, Walsh, Michael, Warman, Rhian, Yogarajah, Mahinda, Nielsen, Glenn ^*, Stone, Jon, Lee, Teresa C, Goldstein, Laura H, Marston, Louise, Hunter, Rachael Maree, Carson, Alan, Holt, Kate, Marsden, Jon, Le Novere, Marie, Nazareth, Irwin, Noble, Hayley, Reuber, Markus, Strudwick, Ann-Marie, Santana Suarez, Beatriz, Edwards, Mark J

Publikováno v: In The Lancet Neurology July 2024 23(7):675-686

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.

Autor: Butler M; Neuropsychiatry Research and Education Group, King's College London, London, England, UK.; Psychoactive Trials Group, King's College London, London, England, UK.; Department of Neuroimaging, King's College London, London, England, UK., Bird C; Psychoactive Trials Group, King's College London, London, England, UK., Maggio C; Psychoactive Trials Group, King's College London, London, England, UK., Durden A; Psychoactive Trials Group, King's College London, London, England, UK., Modlin N; Psychoactive Trials Group, King's College London, London, England, UK., Campbell-Coker K; Psychoactive Trials Group, King's College London, London, England, UK., Edwards M; Neuropsychiatry Research and Education Group, King's College London, London, England, UK., Pick S; Psychological Sciences, King's College London, London, England, UK., Millman LSM; Psychological Sciences, King's College London, London, England, UK., Lowery E; Neuropsychiatry Research and Education Group, King's College London, London, England, UK., Bhagavan C; Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.; Austin Health, Heidelberg, Victoria, Australia., Kanaan R; Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.; Austin Health, Heidelberg, Victoria, Australia., Golder D; FND Hope, Salmon, Idaho, 83467, USA., Mildon B; FND Hope, Salmon, Idaho, 83467, USA., Mehta M; Department of Neuroimaging, King's College London, London, England, UK., Rucker J; Psychoactive Trials Group, King's College London, London, England, UK., Nicholson TR; Neuropsychiatry Research and Education Group, King's College London, London, England, UK.

Publikováno v: Wellcome open research [Wellcome Open Res] 2024 Jul 24; Vol. 9, pp. 401. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).